Literature DB >> 15147511

TorsinB--perinuclear location and association with torsinA.

Jeffrey W Hewett1, Christoph Kamm, Heather Boston, Roberta Beauchamp, Teri Naismith, Laurie Ozelius, Phyllis I Hanson, Xandra O Breakefield, Vijaya Ramesh.   

Abstract

The torsins comprise a four-member family of AAA+ chaperone proteins, including torsinA, torsinB, torp2A and torp3A in humans. Mutations in torsinA underlie early onset torsion dystonia, an autosomal dominant, neurologically based movement disorder. TorsinB is highly homologous to torsinA with its gene adjacent to that for torsinA on human chromosome 9q34. Antibodies have been generated which can distinguish torsinA and torsinB from each other, and from the torps in human and rodent cells. TorsinB (approximately MW 38 kDa), like torsinA ( approximately MW 37 kDa), is an N-glycosylated protein and both reside primarily in the endoplasmic reticulum (ER) and nuclear envelope in cultured cells. Immunoprecipitation studies in cultured cells and human brain tissue indicate that torsinA and torsinB are associated with each other in cells. Overexpression of both wild-type torsinB and mutant torsinA lead to enrichment of the protein in the nuclear envelope and formation of large cytoplasmic inclusions. We conclude that torsinB and torsinA are localized in overlapping cell compartments within the same protein complex, and thus may carry out related functions in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147511     DOI: 10.1111/j.1471-4159.2004.02404.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  RNA interference-mediated inhibition of wild-type Torsin A expression increases apoptosis caused by oxidative stress in cultured cells.

Authors:  Xue-Ping Chen; Xiao-Hui Hu; Shu-Hui Wu; Yang-Wei Zhang; Bo Xiao; Hui-Fang Shang
Journal:  Neurochem Res       Date:  2010-05-09       Impact factor: 3.996

Review 2.  Torsins: not your typical AAA+ ATPases.

Authors:  April E Rose; Rebecca S H Brown; Christian Schlieker
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-10-13       Impact factor: 8.250

3.  Arresting a Torsin ATPase reshapes the endoplasmic reticulum.

Authors:  April E Rose; Chenguang Zhao; Elizabeth M Turner; Anna M Steyer; Christian Schlieker
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

4.  LINCing defective nuclear-cytoskeletal coupling and DYT1 dystonia.

Authors:  Cosmo A Saunders; G W Gant Luxton
Journal:  Cell Mol Bioeng       Date:  2016-02-03       Impact factor: 2.321

5.  Motor deficits and hyperactivity in Dyt1 knockdown mice.

Authors:  Mai T Dang; Fumiaki Yokoi; Morgan A Pence; Yuqing Li
Journal:  Neurosci Res       Date:  2006-10-13       Impact factor: 3.304

6.  Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation.

Authors:  Nutan Sharma; Mark G Baxter; Jeremy Petravicz; D Cristopher Bragg; Alonna Schienda; David G Standaert; Xandra O Breakefield
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

7.  Developmental patterns of torsinA and torsinB expression.

Authors:  Anju Vasudevan; Xandra O Breakefield; Pradeep G Bhide
Journal:  Brain Res       Date:  2006-02-02       Impact factor: 3.252

8.  Thrombospondin expression in myofibers stabilizes muscle membranes.

Authors:  Davy Vanhoutte; Tobias G Schips; Jennifer Q Kwong; Jennifer Davis; Andoria Tjondrokoesoemo; Matthew J Brody; Michelle A Sargent; Onur Kanisicak; Hong Yi; Quan Q Gao; Joseph E Rabinowitz; Talila Volk; Elizabeth M McNally; Jeffery D Molkentin
Journal:  Elife       Date:  2016-09-26       Impact factor: 8.140

9.  Interaction of torsinA with its major binding partners is impaired by the dystonia-associated DeltaGAG deletion.

Authors:  Teresa V Naismith; Seema Dalal; Phyllis I Hanson
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

10.  Alternative nuclear transport for cellular protein quality control.

Authors:  April Rose; Christian Schlieker
Journal:  Trends Cell Biol       Date:  2012-07-31       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.